STOCK TITAN

Surmodics Inc SEC Filings

SRDX NASDAQ

Welcome to our dedicated page for Surmodics SEC filings (Ticker: SRDX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Drug-coated balloons that release therapy in seconds, hydrophilic coatings that keep catheters moving smoothly—Surmodics invents the invisible layers that make modern cardiovascular devices possible. Unfortunately, its regulatory paperwork is almost as intricate as its science. Whether you’re hunting for segment profit in a 10-K or scanning EDGAR for Surmodics insider trading Form 4 transactions, the process is slow. Many professionals end up Googling “Surmodics quarterly earnings report 10-Q filing” or “Surmodics Form 4 insider transactions real-time” just to locate one number. If that’s you, our page delivers Surmodics SEC filings explained simply and streamlines Surmodics earnings report filing analysis.

Stock Titan’s AI reads every word the instant it hits EDGAR, then translates jargon into plain language. Need understanding Surmodics SEC documents with AI? We flag risk factors, chart revenue shifts, and highlight R&D spending inside a Surmodics annual report 10-K simplified to essentials. Real-time alerts ensure Surmodics executive stock transactions Form 4 never slip past you. For governance checks, our platform links every Surmodics proxy statement executive compensation table to prior years, and when surprises strike we provide Surmodics 8-K material events explained within minutes.

With comprehensive coverage of all filing types and AI-powered summaries you can:

  • Compare quarter-over-quarter coating and whole-product revenue without opening spreadsheets
  • Monitor insider activity before material announcements
  • See how new FDA milestones might reshape guidance

Every 10-K, 10-Q, 8-K, S-1 and Form 4 appears here in real time, backed by expert analysis that makes complex documents clear. Skip the download cycle—get decisive insights faster.

Rhea-AI Summary
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Surmodics (SRDX)?

The current stock price of Surmodics (SRDX) is $30.87 as of July 11, 2025.

What is the market cap of Surmodics (SRDX)?

The market cap of Surmodics (SRDX) is approximately 428.8M.

What is the core business of Surmodics Inc.?

Surmodics Inc. focuses on developing advanced coating technologies and integrated product solutions for the medical device, diagnostic, and life sciences industries.

How does Surmodics generate revenue?

Revenue is primarily generated through strategic collaborations and partnerships with medical device, diagnostic, and life sciences companies, leveraging their expertise in technology development and product innovation.

What sets Surmodics apart from its competitors?

Surmodics distinguishes itself by evolving from a provider of solely coating technologies to offering comprehensive, whole-product solutions that address complex healthcare challenges.

What industry challenges does Surmodics address?

The company targets critical issues including the reliability and performance of medical devices, enabling improved detection and treatment of diseases through innovative coating and product integration.

What role do partnerships play in Surmodics' business model?

Partnerships are crucial as they enable Surmodics to integrate diverse technical expertise and resources, facilitating the development of customized solutions for some of the world’s leading medical device and diagnostic companies.

How does Surmodics ensure product quality and innovation?

With a strong focus on research and development, Surmodics continually invests in new technologies and manufacturing processes, ensuring that its products meet high standards of performance and reliability.

In which market segments does Surmodics operate?

Surmodics operates primarily in the medical device, diagnostics, and life sciences segments, offering both advanced coating technologies and integrated product solutions tailored to these markets.

Can you explain the evolution of Surmodics' product offerings?

Initially known for its coating technologies, Surmodics has expanded its portfolio through recent acquisitions to offer whole-product solutions, catering to increasingly complex challenges in disease detection and treatment.
Surmodics Inc

NASDAQ:SRDX

SRDX Rankings

SRDX Stock Data

428.83M
13.74M
3.41%
87.05%
1.9%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
EDEN PRAIRIE